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Eukaryotic initiation factor 4E (eIF4E) plays central roles in the control of several 
aspects of mRNA metabolism, and affects developmental processes as well as human 
diseases. This review explores the relationship between structural, biochemical and 
biophysical aspects of eIF4E and its function in vivo, including both long-established 




The production of proteins is regulated at many different steps of gene expression in 
order to control both the amount and the nature of the final product. One of the steps 
that are subject to tight regulation is the recruitment of the small ribosomal subunit to 
mRNA in preparation for the initiation of protein synthesis. Decoding of an mRNA 
during translation proceeds in the 5’→3’ direction. The recruitment process therefore 
needs to facilitate placement of ribosomes at the 5’end of the message. Moreover, the 
frequency of ribosome binding to the mRNA has to match the amount of the encoded 
protein required by the cell. 
In eukaryotes, two principal pathways are available for attachment of the small 
ribosomal subunit 5’ of the translated region. The first, termed cap-dependent 
translation initiation, relies on the fact that eukaryotic mRNAs are co-transcriptionally 
modified by attachment of an inverted, methylated guanine moiety to produce the 5’-
terminal cap-structure m7GpppN (where N is the first transcribed nucleotide1). The 
cap serves as a point of anchorage for a cap-binding protein complex that can mediate 
recruitment of the small subunit of the ribosome to the extreme 5’end of the mRNA 
(Fig. 1). A second pathway utilizes complex secondary structure elements in the 
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RNA, so called internal ribosomal entry segments (IRES), to recruit small ribosomal 
subunits either via direct RNA–ribosome contacts or indirectly via initiation factors 
that can bind both the IRES and the ribosome. Initiation via this pathway does not rely 
on the existence of a cap-structure on the mRNA, and is therefore termed cap-
independent. The overwhelming majority of eukaryotic transcripts are translated in a 
cap-dependent manner, and this review will focus only on this mode of translation.  
Since the cap-structure is located at the very 5’-end of the transcript, cap-
dependent translation initiation recruits the small ribosomal subunit to a point that is 
separated from the translation start codon by an untranslated region (5’UTR) up to 
several hundreds of nucleotides long. Following recruitment to the 5’end, the 
eukaryotic small ribosomal subunit therefore has to locate the start codon by means of 
a processive 5’→3’ scanning process. Once this codon has been reached, the large 
ribosomal subunit binds to the small ribosomal subunit and protein synthesis can 
begin (for general reviews on translation initiation see refs. 2–4). 
The protein complex that is responsible for recruiting small ribosomal subunits 
comprises the cap-binding protein eIF4E, the large adaptor protein eIF4G, and the 
poly(A) binding protein PAB (Pab1 in yeast), which binds to the poly(A) tail present 
on 3’-ends of most eukaryotic transcripts (Fig. 1b). Binding of eIF4E and eIF4G to 
the cap via the activity of eIF4E is absolutely essential for translation both in vivo and 
in vitro. On the other hand, contacts between eIF4G and the poly(A)-bound PAB 
appear to enhance translation efficiency but are not absolutely required for ribosome 
recruitment. This stimulatory effect may be linked to circularization of the mRNA 
that can be mediated by the cap–eIF4F–poly(A) tail bridge. Since any break in the 
chain cap–eIF4E–eIF4G impairs cap-dependent translation, the assembly of this 
complex is a potential target for translational control. Evidence for such control has 
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been found during developmental processes5 and tumorigenesis6, and eIF4E has 
consequently been identified as a potential drug target7.  
Despite the fact that eIF4E was identified as a translation factor more than 25 
years ago and considerable effort has been spent on elucidating the function of this 
key protein, there are still many unanswered questions concerning its biological role. 
One of the problems is that the regulation of translation is linked to the control of 
mRNA export and mRNA turnover. Indeed, the involvement of eIF4E in these 
processes has only recently become evident. It appears that all of the functions of 
eIF4E are linked to the presence on this factor of binding sites for both the mRNA cap 
and for a number of proteins, and that the particular function of any individual eIF4E 
molecule depends on the type of protein ligand it is bound to. In the following, we 
will therefore review currently available data on the physical basis of eIF4E–mRNA 
and eIF4E–protein interactions, and then relate these data to biological functions. The 
influence of phosphorylation on eIF4E function is a controversial issue that has 
recently been reviewed in some detail8, and we have accordingly given only minimal 
consideration to it here. 
 
The interaction of eIF4E with nucleic acids 
The structural basis of cap-binding – eIF4E specifically binds the 5’-end cap-
structures of mRNAs, which in most eukaryotes are of the types m7GpppNp, 
m7GpppNmp or m7GpppNmpNmp1 (where m denotes a methyl-group attached to the 
respective nucleotide, see Figure 2a). A number of three-dimensional structures have 
been solved for eIF4E–cap analog complexes, from which molecular contacts 
between eIF4E and mRNA 5’ ends were identified9–14. The cap-binding site is formed 
by a cavity in the otherwise roughly spherical body of eIF4E. Two tryptophan 
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residues are situated near the upper and lower fringes of this cavity. When the cap-
analog m7GTP is bound, the guanosine moiety is stacked between the two 
tryptophans, and held in place through interactions between the ring systems of the 
three components (Fig. 2b). A strong stabilizing effect is associated with the presence 
of the methyl group, which introduces a positive charge on this moiety that greatly 
enhances the stacking interaction14.  
This preferred binding to methylated guanosine is of biological relevance 
because intracellular levels of GTP are in the millimolar range in logarithmically 
growing yeast cells15 and thus three to four orders of magnitude higher than the levels 
of eIF4E or mRNAs16. Efficient binding to unmethylated GTP would thus strongly 
interfere with mRNA 5’-end binding. The equilibrium affinity for the eIF4E–m7GTP 
interaction is almost five orders of magnitude higher than that for the interaction with 
GTP14, and thus under equilibrium conditions the majority of eIF4E is bound to cap-
structures despite the high GTP concentrations.  
In contrast to GTP and GDP, their methylated counterparts bind to eIF4E with 
high affinity. m7GDP is generated during the decapping step in the mRNA 
degradation pathway (see below). Its interference with the process of translation 
appears to be prevented in yeast and humans by the existence of a dedicated enzyme 
pathway that rapidly degrades this compound17. 
In addition to the influence of stacking interactions, mRNA caps are stabilized 
inside the cap-binding cavity by several van-der-Waals contacts and hydrogen bonds 
with the three phosphate groups and the ribose of the cap-analog. Comparisons of the 
free energies of m7G, m7GMP, m7GDP and m7GTP-binding showed that about half 
the total binding energy of the m7GTP–eIF4E-bond derives from van-der-Waals 
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contacts and hydrogen bonds, with the other half derived from the stacking of the ring 
systems14. 
 
Binding of eIF4E to mRNAs with different 5’-end sequences – Since the methylated 
guanosine is an invariant component present on all capped transcripts, molecular 
contacts with the cap are identical independent of the mRNA species. In contrast, if 
contacts with downstream nucleotides exist, the overall affinity of eIF4E for mRNA 
5’-ends could be transcript-dependent, and this could theoretically affect the 
efficiency of translation in a transcript-dependent manner. 
NMR-studies and X-ray crystallographic analyses of eIF4E in complex with 
the larger cap-analog m7GpppA showed that additional contacts exist between the C-
terminus of the protein and the adenine13,18,19. Interestingly, Niedzwiecka et al. found 
that the affinity of m7GpppN cap-analogs differed according to the nature of the 
second nucleotide14, following the order m7GpppG>m7GpppA>m7GpppC. 
In addition, nucleotides downstream of the cap may contribute to eIF4E-
binding. Studies with the human protein showed that several of the nucleotides after 
the cap may contact the body of eIF4E, and that altering the sequence close to the cap 
produces up to four-fold variations in equilibrium affinity20,21. However, NMR 
experiments using capped trinucleotide RNAs showed no detectable intermolecular 
contacts beyond the first nucleotide following the cap-structure19, so that any binding 
of downstream nucleotides to the body of the protein is likely to be weak. Whether the 
observed differences in mRNA cap-affinity are sufficiently strong to affect 
translational efficiency significantly is currently unclear. 
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Structural differences in cap-bound and apo-eIF4E – A number of observations 
suggest that small conformational changes in the overall structure of eIF4E are closely 
linked to cap binding. The loops forming the outer fringes of the cap-binding pocket 
are relatively flexible portions of eIF4E both according to NMR data18 and to 
Molecular Dynamics simulations13, and a decrease in flexibility is predicted following 
binding of mRNA ends13. Moreover, the secondary structure content of the cap-
binding protein appears to be altered in the presence of cap-analogs, since addition of 
the latter produces subtle changes in CD spectra recorded for eIF4Es from various 
organisms22–24. Consistent with these observations, cap-bound and apo-eIF4E show 
differing behavior in some biochemical assays24,25.  
These structural differences indicate that some or all of the binding partners of 
the cap-binding protein may be able to distinguish between its cap-bound and 
unbound state. Indeed, it has been shown that the association of small translational 
inhibitors, the 4E-binding proteins (4E-BPs), with human eIF4E is significantly 
increased for the cap-bound form25. 4E-BPs act by competing with eIF4G for binding 
to eIF4E, thus preventing the formation of translationally active eIF4E–eIF4G–
mRNA complexes (Fig. 1a). The above observation therefore has important 
implications for the regulatory properties of the 4E-BPs, because the preferential 
binding to cap-bound eIF4E increases the proportion of cap-bound versus free 4E-
BP–eIF4E complexes.  
 
Affinity of the cap-interaction – A large number of studies using a range of 
experimental techniques have established that the equilibrium affinity of the eIF4E–
mRNA cap interaction is in the range of 0.1–4 µM, depending on the source of the 
protein, and the pH and salt conditions under which the experiments were 
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performed21,26–31. Kinetically, the interaction is characterized by a very rapid binding-
release cycle14,22. The rapid association is thought to be the result of strong 
electrostatic steering of the negatively charged mRNA cap towards the cap-binding 
site, due to a large dipole moment of eIF4E32. The resulting complexes are unstable 
and decay with a half-live of ~ 0.1 seconds (based on dissociation rates measured for 
the human protein31). 
These kinetic characteristics indicate that apo-eIF4E, which is non-functional 
for the purposes of translation since this protein can recruit ribosomes only in 
complex with eIF4G, leaves cap-structures again rapidly after binding to them. In 
contrast, eIF4E in complex with protein ligands has been found to undergo more 
stable interactions with mRNA 5’-ends using a variety of mechanisms (discussed in 
more detail below). In consequence, any cellular pool of free eIF4E does not compete 
efficiently with the translationally active eIF4E–eIF4G complexes for cap binding. 
Free eIF4E therefore becomes a relevant competitor for the latter only upon binding 
of a translationally inactive ligand that also increases cap-affinity (e.g. 4E-BP). 
 
Protein-protein interactions of eIF4E  
Binding of eIF4G – Two independent studies employing mutants of yeast eIF4E33 
and X-ray crystallography of murine eIF4E10 identified a coherent epitope formed by 
residues originating from strand 1, helix 1 and helix 2 (numbering for the human 
protein9) that is required for binding to eIF4G. The binding site thus identified is 
distal from the cap-binding pocket, and does not contain any known residues involved 
in cap binding. 
Subsequent experiments with larger fragments of eIF4G concluded that 
contacts between the full-length proteins include additional residues34. An NMR study 
 9
of a yeast m7GDP–eIF4E–eIF4G393–490 complex showed that the N-terminal tail of 
eIF4E and the eIF4G-fragment, both of which are unstructured in the apo-proteins, 
mutually induce extensive folding events that result in a complex, interlocking 
structure12 (Fig. 2c. The secondary structure elements in the eIF4G393–490 fragment 
shown in blue in this panel are detectable only in the eIF4E-bound form, but not in 
apo-eIF4G393–49034.) The binding reaction leading to this interlocking structure is 
thought to occur in two stages, an initial encounter involving the minimal binding site 
identified earlier, followed by a collapse of disordered parts of eIF4E and eIF4G into 
the compact, folded structure. Consistent with the extensive binding interface, the 
resulting complex is stable with a kD of 2–4 nM and a half-life of five to six minutes 
(kdiss ~ 2x10-3 s-1)12,33. 
Since the 393–490 fragment of yeast eIF4G1 is unstructured in solution and 
becomes folded only when in contact with eIF4E, the question arises how the eIF4E 
binding site is organized in full-length eIF4G. Deletion of N-terminal residues of the 
cap-binding protein weakens its interaction with eIF4G1393–490 in vitro, and also 
reduces the ability of eIF4E to mediate pull-down of full-length eIF4G from cell 
extracts12. It is therefore likely that contacts with the N-terminal tail that are crucial 
for formation of the interlocking eIF4G393–490–eIF4E interface are similarly important 
for the interaction with full-length eIF4G. If a similar unfolded-to folded transition 
occurs in the latter as is observed for the fragment in vitro, the eIF4E-binding site can 
be predicted to form an unfolded loop in an otherwise folded protein, since a 
conserved part of eIF4G adjacent to this site has recently been shown to fold into a 
HEAT domain35. A disordered binding site would be consistent with observations by 
Berset et al. that yeast eIF4G expressed in E. coli can be protected from proteolysis 
by co-expression of eIF4E36. However, with only limited structural data available on 
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the eIF4G N-terminal domain, the exact nature of the eIF4E binding site in the 
context of the full-length protein remains elusive. 
 
Interactions with other proteins – Binding of the 4E-BPs to eIF4E was shown to 
occur via the region centering around the W73 residue of eIF4E that is also required 
for eIF4G-binding10,30. The interactions of peptides corresponding to minimal eIF4E 
binding sites on the 4E-BPs mimic the interaction of the corresponding eIF4G peptide 
closely10. 4E-BPs are relatively small proteins (~12 kDa) that show no obvious 
structure in solution, and undergo a folding transition around the eIF4E binding site 
upon interaction with this factor. However, parts of the 4E-BPs outside of the binding 
region remain largely unfolded37. Subtle differences in the ways eIF4G and the 4E-
BPs contact eIF4E were also observed in two-hybrid studies with mutant cap-binding 
proteins30, but it is at present not known whether the different contact surfaces of 
eIF4E-ligands are the result of differences in the unfolded-to-folded transition.  
In addition to the 4E-BPs, various organisms have a number of other 4E-
binding partners that compete with the formation of translationally active eIF4E–
eIF4G-complexes. These are generally larger proteins than the 4E-BPs, and can 
assume highly specialized roles during particular developmental stages. Examples for 
such proteins are Maskin in Xenopus38, and Cup39 and Bicoid40 in Drosophila. To 
date, nothing is known about the structural organization of the eIF4E-binding site in 
these proteins.  
In humans, two further proteins have been identified as binding partners of 
eIF4E that appear to serve as negative regulators of the eIF4E-dependent export of a 
subset of mRNAs. These are the Promyelocytic Leukemia Protein (PML) and the 
Proline-Rich Homeodomain protein (PRH)24,41. It is known that interactions of these 
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proteins with eIF4E show the same sensitivity to mutations of the W73 residue on the 
cap-distal surface of eIF4E as do interactions of eIF4G and the 4E-BPs24,41, despite 
the fact that PML and PLH do not contain the conserved minimal eIF4E-binding 
motif Tyr-X-X-X-X-Leu−φ (where φ is Leu, Met or Phe)42 found in the latter 
proteins. While PRH contains a related motif in which the hydrophobic φ is 
exchanged for a polar Gln41, the 60-residue region in PML identified as the eIF4E-
binding domain does not contain any motif of similar sequence43. Thus, all known 
protein binding partners of eIF4E bind to a common region on the cap-distal side of 
this protein, although the details of the molecular contacts involved in these 
interactions may vary considerably. 
 
Ligand-dependent stabilization of the eIF4E–cap interaction 
While the interaction of apo-eIF4E with cap-structures is transient, it is significantly 
stabilized following eIF4G binding22,27,33,44. It was originally proposed that this is 
attributable to the RNA-binding activity of eIF4G44. However, an alternative 
explanation is that eIF4G imposes conformational changes on eIF4E that stabilize cap 
binding33. In vivo, a combination of both mechanisms may determine the overall 
stability of the mRNA 5’-end associated eIF4E–eIF4G–PAB complex.  
 
Stabilization of cap-binding through conformational changes – Slower dissociation 
of eIF4G-bound than of free eIF4E has been observed from cap-analogs that do not 
contain additional nucleotides to which eIF4G could bind, and also with fragments of 
eIF4G that bind to eIF4E but not to RNA22,27,33. In both types of experiment, RNA 
binding activity of eIF4G can be ruled out as the source of stabilization, and allosteric 
effects on the conformation of eIF4E are the most likely cause of the cap-arrest. 
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Mapping of chemical shifts in eIF4E following eIF4G binding reveals small 
changes in the structure or flexibility of key residues within the cap-binding site of 
eIF4E12. While it remains to be formally proven that these changes are causally linked 
to stabilization of the eIF4E–cap interaction, it was shown that both these changes and 
the increased binding to capped RNAs depend on the extensive folding events that 
occur during the eIF4E–eIF4G interaction12. Thus, important determinants of the 
eIF4E–cap interaction are situated outside the consensus binding motifs in both eIF4E 
and eIF4G, and these determinants are not present in the N-terminally truncated 
proteins employed in many of the published biophysical studies of human eIF4E.  
In addition to the stabilizing effect of eIF4G binding to eIF4E, binding of the 
poly(A) binding protein PAB to the eIF4E–eIF4G complex further stabilizes the cap-
interaction. This effect was shown in vitro for the purified proteins from wheat45,46, 
humans47 and yeast22. PAB binding to eIF4G is itself enhanced by contacts with 
poly(A) RNA48, so that maximal cap-binding activity is likely to depend on full 
formation of the molecular chain cap–eIF4E–eIF4G–PAB–poly(A). However, weaker 
stabilizing effects are likely to occur also for subcomplexes in which individual links 
in this chain are broken. 
 
Allosteric effects caused by other ligands – As is the case for eIF4G, reduced 
dissociation of eIF4E from cap-structures has also been observed in the presence of 
4E-BPs30,31. In studies of the latter proteins, binding and release kinetics for eIF4E–
4E-BP complexes were observed that are equivalent to an apparent half-life for cap-
dissociation of ca. 14 minutes (kdiss ~ 8x10-4, refs. 30,31). 
Interestingly, a modulation of the cap-binding activity of eIF4E has also been 
demonstrated for PML, binding of which reduces eIF4E’s cap-affinity 100-fold43. A 
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somewhat weaker reduction in cap-affinity was likewise found following binding of 
PRH41. This negative effect on cap-binding of eIF4E is likely to be directly linked to 
the regulatory role of PML and PRH in eIF4E-dependent mRNA export, since 
mutants of eIF4E with reduced cap-affinity were shown to be less active in this 
particular type of export than the wild type protein24. 
 
Stabilization of cap-binding through mRNA contacts of eIF4G - Since the affinity 
of eIF4G for RNAs is in the nM range27,36, a direct eIF4G–RNA contact could also 
make significant contributions to a stabilization of the cap-binding complex on 
mRNA 5’ ends. The overall stability of the cap-binding complex in vivo would then 
be determined by a combination of conformational changes in eIF4E that lead to 
slower dissociation rates from the cap, and the RNA-binding activity of eIF4G. In 
yeast eIF4G, it is known that the RNA binding interface is composed of three 
independent mRNA binding sites36. It is currently not clear how this interface is 
organized in the context of the cap-binding complex, and the relative contributions of 
allosteric effects and mRNA contacts to the determination of cap-complex stability in 
vivo can therefore not yet be assessed. 
 
A role of eIF4E for limiting translation initiation in vivo? 
eIF4E is attributed with an often-cited role in limiting the translational activity of 
cells49, based on the original observation that it is less abundant than other initiation 
factors in mammalian cells and reticulocyte lysates50,51. The precise relationship 
between eIF4E levels and translational activity is an important problem, because 
changes in the abundance or activity of eIF4E occur in many situations, from the 
adaptation to environmental stresses52 to developmental decisions5 and 
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tumorigenesis6. However, although changes in eIF4E abundance or activity appear to 
correlate with altered translational activity in these situations, it is not always 
understood whether the two are causally linked. 
In theory, biochemical studies on the interactions of eIF4E with its binding 
partners can provide all the information required to decide whether the availability of 
this protein limits translation. The questions that need to be answered for this kind of 
analysis are, what are the relative levels of mRNAs, eIF4E, eIF4G and other eIF4E-
binding partners; how often do eIF4E–eIF4G complexes need to form on an mRNA in 
order for efficient ribosome recruitment to occur, and how well do eIF4E–eIF4G 
complexes compete with the translationally inactive free eIF4E or with eIF4E–4E-BP 
complexes for access to mRNA ends. 
 
Relative levels of cap-binding complex components and mRNAs – While it was 
initially reported that eIF4E occurred at much lower levels than other initiation factors 
in the reticulocyte system50, newer results indicate that reticulocyte extracts contain an 
excess of eIF4E over eIF4G14,53. Moreover, in yeast, eIF4E was shown to occur at 
levels equimolar to ribosomes and most other initiation factors16,42. As observed in 
yeast, eIF4E is more abundant than eIF4G in all developmental stages of Drosophila 
(Rolando Rivera Pomar, Max Planck Institute for Biophysical Chemistry, Göttingen, 
Germany, pers. comm.). 
The relative abundance of 4E-BPs compared to eIF4E and eIF4G has not yet 
been experimentally determined. However, under active growth conditions the 4E-
BPs exist in a hyperphosphorylated state (see e.g. ref. 54) that prevents efficient 
binding to eIF4E55. Under such conditions, the cap-binding protein is therefore likely 
to exist mainly in complex with eIF4G or in the apo-form. In yeast, reticulocytes and 
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Drosophila cells, it is thus more likely that the availability of eIF4G (rather than that 
of eIF4E) limits the frequency with which ribosomes can be recruited to any 
individual mRNA, or that both factors occur at saturating levels that do not limit 
translational activity at all. 
Under conditions where cells are not actively growing and the requirement for 
protein synthesis is reduced, the 4E-BPs become dephosphorylated and thus able to 
bind to eIF4E. The availability of free eIF4E will then be reduced, and this may limit 
the amount of eIF4E–eIF4G complexes that can be formed. The extent to which this 
affects translation would depend on the level of 4E-BP dephosphorylation as well as 
on the efficiency of competition of eIF4E–4E-BP complexes for cap-access with 
eIF4E–eIF4G complexes.  
 
Frequency of complex formation – While cap-complex formation is known to be 
essential for cap-dependent translation, there is no clear idea about how often this 
complex has to be formed for recruitment of a single ribosome to occur. At one 
extreme would be a situation where the cap-complex is very unstable, and one 
ribosome-recruitment is on average the result of several cap-binding and -release 
cycles. Under such conditions, both eIF4E and eIF4G could potentially limit 
translational activity even if they occurred in excess over mRNAs, since an increase 
in their concentration could affect the frequency with which cap-binding complexes 
are formed.  
At the other extreme, cap-complexes would be bound very stably to mRNA 
ends, sequentially recruiting several ribosomes without dissociating. In such a 
scenario, and if the 4E-BPs are assumed to be fully phosphorylated, nearly all mRNA 
ends would be stably bound to eIF4E–eIF4G complexes as soon as the levels of these 
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complexes match those of mRNAs. If both eIF4E and eIF4G occurred in excess over 
mRNAs, they would then be present at saturating levels, and the availability of neither 
protein could limit translational activity.  
The biophysical data derived from in vitro experiments with recombinant 
eIF4E, eIF4G and PAB as described above indicate that cap-binding complexes are 
stable and dissociate relatively slowly from mRNAs. This would indicate that several 
ribosomes are usually recruited without the cap-binding complex being released and 
rebound. However, Ray et al. showed that, in cap-binding assays employing purified 
human proteins, the addition of eIF4B (a protein that stimulates the helicase activity 
of eIF4A56) destabilized pre-assembled cap-complexes that also contained eIF4A, and 
led to an accelerated binding and release cycle57. In vivo, the action of eIF4B and 
possibly other trans-acting factors may therefore alter cap-complex stability compared 
to pure in vitro systems.  
 
Effects of experimentally altered eIF4E levels - Given the difficulties in 
extrapolating kinetic constants estimated in vitro in terms of eIF complex stability in 
vivo, the engineering of variations in the abundance of eIF4E within cells is a valuable 
approach. Results from such experiments indicate that changes in the concentration of 
eIF4E produce two distinct types of response, relating to bulk translation on the one 
hand and specific aspects of cellular metabolism on the other.  
In yeast, overexpression of eIF4E by up to a factor 100 has only a minor effect 
on growth rates58. Similarly, a 2.5-fold increase of eIF4F levels did not lead to 
increased general translation rates in feline cardiocytes59; while a modest increase in 
translation rates could be observed in other systems such as Xenopus cells60. Thus, 
bulk translation in these systems appears to be quite insensitive to increases in eIF4E 
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availability. Reduction of the intracellular eIF4E-levels to 30% of wild-type levels is 
tolerated in yeast without apparent effects on growth rate or amino acid 
incorporation16. Here, translation is affected as soon as eIF4E levels fall close to or 
below mRNA levels. In other organisms, smaller reductions of eIF4E levels have 
more dramatic effects, possibly because the natural levels of eIF4E are closer to those 
of total mRNA than in yeast.  
Taken together with the considerations in the previous section, these results 
suggest that, at least under conditions of high translational activity, eIF4E levels are 
not limiting general translation.  
Interestingly, changes in eIF4E levels that do not or only moderately affect 
bulk translation can have measurable effects on cellular physiology. Thus, eIF4E 
overexpression can cause malignant transformation while reduction of eIF4E levels 
can reverse the transformed phenotype. High eIF4E-levels are observed in an 
increasing number of cancers, and the level of overexpression often correlates with 
the severity of the disease6, although the mechanisms underlying these effects are 
unknown. In yeast, reductions in eIF4E levels that do not affect methionine 
incorporation into protein clearly affect cell morphology, ribosome biogenesis, and 
the cells’ ability to progress through the cell cycle16,61.  
 
eIF4E and transcript-specific regulation of gene expression 
One explanation for the striking discrepancy between bulk translation levels and other 
effects following eIF4E activity changes might be that some growth-critical mRNAs 
have special requirements with respect to eIF4E function. Specific regulation of this 
kind has been suggested for CyclinD162, ODC63, FGF-264, Pim-165 and VPF66 
mRNAs in mammals, as well as for CLN3 in yeast61. Two possible mechanisms have 
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been put forward in the literature to explain how eIF4E might affect translation of 
these messages in transcript-specific ways. 
Firstly, particular sensitivity to eIF4E-levels might arise from differential 
affinity of cap-binding complexes for different transcripts. As we described in the 
beginning of this review, such differences are likely to be only weak, and will not 
strongly affect mRNA binding if eIF4E and eIF4G are present at saturating levels. As 
soon as the amount of eIF4E–eIF4G complexes approaches limiting levels, however, 
lower-affinity mRNA ends are in direct competition for the available cap-binding 
complex with more tightly bound messages. This could significantly limit cap-
complex assembly on less tightly bound mRNAs, while having only a small effect on 
messages that bind the cap-binding complex with higher affinity. Preferential binding 
of one RNA species over another at low concentrations of eIF4E and eIF4G has been 
experimentally shown in vitro for different species of Reovirus RNA67.  
Second, mRNAs regarded as sensitive to available eIF4E levels usually 
feature long and structured 5’ UTRs that interfere with efficient recruitment of the 
40S subunits, and it was suggested that this increases the dependency of translation on 
eIF4A-mediated RNA helicase activity49. Since it is one of the roles of the cap-
binding complex to recruit eIF4A to mRNA 5’ ends, where this protein is thought to 
remove secondary structure in preparation of ribosome binding, limitations in cap-
complex assembly might also limit 5’-UTR unwinding. At least theoretically, relief 
from this limitation could affect structured UTRs more than bulk mRNA. In support 
of this prediction, it was recently reported that the requirement for eIF4A correlates 
directly with the stability of secondary structures present in mRNA 5’ UTRs68.  
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Transcript-specific control of mRNA export – The discussion about transcript-
specific regulation via eIF4E is complicated by the fact that nuclear export of some 
mRNAs is dependent on eIF4E activity, and that there is some overlap between this 
and translational sensitivity to eIF4E levels (Fig. 3). Thus, the human CyclinD1 
message and other mRNAs are exported via an eIF4E-dependent mechanism. 
Although eIF4E-dependent mRNA export is mechanistically still poorly defined, it 
appears now likely that such a mechanism exists. Such a link might render protein 
production sensitive to eIF4E levels independently of translational control41,69.  
The two assays usually employed to identify transcript-specific translational 
control via eIF4E are polysomal gradient analysis and reporter gene measurements, 
under conditions of normal and increased eIF4E levels. Neither assay can readily 
distinguish between the utilization of an existing cytoplasmic pool of untranslated or 
poorly translated mRNAs (which would correspond to direct translational control) and 
changes in the size of a cytoplasmic pool caused by increased nuclear export. The 
finding that overexpression in mammalian cells of a W73A mutant of eIF4E, which 
can not function in translation but is active for CyclinD1 mRNA export, has the same 
transforming properties as overexpression of the wild-type protein24, suggests that the 
oncogenic properties of the cap-binding protein may be coupled to the control of 
mRNA export.  
Interestingly, the requirement for eIF4E outside the process of translation 
provides a potential explanation for the existence of a cooperative cap-binding 
mechanism. Such a mechanism would enable cells to maintain a pool of free eIF4E 
that might participate, for example, in nuclear export, yet not compete efficiently with 
eIF4E–eIF4G complexes for cap-access.  
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eIF4E and regulation of mRNA turnover 
Pathways of mRNA degradation - Removal of the cap-structure from mRNAs is a 
key step in some pathways of mRNA degradation, namely those that involve 5’→3’ 
exonuclease activities which are blocked by the presence of the cap (reviewed in ref. 
70). Dedicated decapping enzymes have been found in a number of organisms, the 
best characterized of which are the yeast Dcp1 and Dcp2 enzymes. Dcp activity 
cleaves cap-structures between the second and third phosphate bond, yielding m7GDP 
and a 5’-monophosphorylated RNA that is a substrate for 5’→3’exonucleases such as 
Xrn1. Cleavage of the cap requires access to parts of the cap-structure that are in 
direct contact with eIF4E, and competition between eIF4E and Dcp activity has been 
experimentally shown both in vitro71,72 and in vivo72,73. This suggests that increases in 
the activity of eIF4E and eIF4G might, at least under certain conditions, lead to 
mRNA stabilization, whereas the transition from translation to decapping and 
degradation should coincide with cap-binding complex destabilization.  
 
Control of mRNA degradation by eIF activity - The major pathway of mRNA 
degradation in yeast requires that decapping be preceded by shortening of the poly(A) 
tail to approximately 10 nucleotides, which is just below the number of adenine 
residues to which the poly(A)-binding protein Pab1 optimally binds48. A simple, 
testable model for the control of degradation can accordingly be constructed that uses 
poly(A) tail length as a master controller for cap-complex stability (Fig. 4, left 
branch). The idea is that a newly exported, polyadenylated mRNA is bound to Pab1, 
which increases the affinity of the cap-binding complex for this mRNA’s cap 
structure. This leads to efficient recruitment of ribosomes, as well as efficient 
protection against Dcp activity. During this translation stage, the poly(A) tail is 
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progressively shortened, until its length drops below the minimum length to which 
Pab1 can bind. Since Pab1 is then no longer in contact with poly(A), it loses its ability 
to bind eIF4G and exert a stabilizing effect on the eIF4G–eIF4E–cap interaction. The 
subsequent dissociation of eIF4E renders the cap accessible to Dcp activity, which 
may be actively recruited to mRNA 5’ ends via interactions of Dcp1 and Dcp2 with 
other proteins71.  
Although this model is attractive because it can explain many of the features 
of mRNA turnover observed in vivo by a relatively simple mechanism, there are a 
number of observations suggesting that the connection between poly(A) tail length 
and mRNA turnover in cells is more complicated. Most importantly, while deletion of 
the entire PAB1 gene clearly uncouples deadenylation from decapping74, both 
processes operate normally in yeast strains containing mutants of Pab1 that can bind 
to poly(A) but not to eIF4G75. Pab1 may therefore influence decapping via multiple 
(parallel) routes, only one of which might involve modulation of the access of eIF4E 
and Dcp to the mRNA cap.  
 
Indirect control of degradation - There are several accessory activities required for 
efficient removal of the cap. Among these are the RNA helicase Dhh1, and the 
enhancers of decapping Edc1 and Edc2, the Lsm1-7 proteins and the mRNA binding 
protein Pat176–78. Since, for example, Dhh1 deletion strains show normal 
deadenylation, but accumulate capped transcripts76, Dcp-access to the cap is likely to 
be subject to complex regulation. 
The accessory activities named above appear to associate with mRNAs in a 
large protein complex, and this association appears to occur after deadenylation but 
prior to decapping78. Since mRNAs bound to this complex were shown to be no 
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longer in contact with eIF4E or eIF4G, it is likely that Lsm1-7 and its associated 
factors compete with eIF4E for cap-access before the decapping enzymes become 
active, rather than the Dcps directly competing with eIF4E. Interestingly, one of the 
proteins implicated in formation of this complex is the RNA helicase Dhh176, which 
may potentially be involved in active dissociation of eIF4E prior to decapping. Thus, 
a possible sequence of events during the transition from translation to mRNA 
degradation is that co-translational shortening of the poly(A) tail to around ten 
nucleotides triggers association of the Lsm1-7 complex with an RNA (Fig. 4, right 
branch). This might then lead to dissociation of the cap-binding complex, allowing the 
Lsm1-7-bound Dcp proteins access to the cap. It is currently unclear how the 
exchange of eIF4E–eIF4G for Lsm1-7 is achieved. However, Pat1 activity has been 
implicated in this process since this is the only Lsm-complex associated protein that 
has also been detected on eIF4E-bound mRNAs78.  
 
Effects of protein localization - Attempts to understand the mechanism that converts 
translationally active mRNPs into substrates for mRNA decay are further complicated 
by recent observations that translation and degradation may occur in different 
cytoplasmic compartments. Thus, enzymes involved in mRNA decay are concentrated 
in cytoplasmic foci (termed P-bodies) in S. cerevisiae, and these foci are also enriched 
for intermediate products of the mRNA degradation pathway79. In S. pombe, the 
essential eIF4E1 isoform and the stress-response-linked, translationally inactive 
isoform eIF4E2 seem to be located in distinct cytoplasmic bodies that are similar in 
shape to the budding yeast P-bodies80. These observations suggest that transitions of 
mRNAs between different functional states, and the exchange of cap-associated 
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factors, might involve relocalization within the cell. The role of compartmentalization 
in the control of posttranscriptional processes clearly requires further investigation.  
 
Future challenges 
Since its identification 25 years ago, eIF4E has become one of the best-characterized 
translation initiation factors. A major challenge for workers in this area derives from 
the fact that several intracellular modulators influence the properties of eIF4E, and 
thus its function(s), in vivo. Thus, the presence of competitive binding inhibitors, the 
various allosteric effects of interacting proteins, as well as the generally overcrowded 
molecular environment, all contribute to the complex functional behavior of eIF4E in 
the cell.  
Despite this complexity, recently published data on the biophysical 
characteristics of eIF4E have shed new light on in vivo function. Moreover, the broad 
spectrum of experimental methods described in this review is likely to yield answers 
to many further important questions. For example, it remains to be determined 
whether all mRNAs whose translation is apparently eIF4E-sensitive are subject to 
genuine translational control, as opposed to transcript-specific control at the level of 
nuclear export or mRNA degradation. Other open questions concern the network of 
interactions responsible for switching between cap-dependent translation and mRNA 
decapping and the role of compartmentalization. Detailed quantitative molecular 
analyses of eIF4E and its interaction partners will undoubtedly continue to provide 
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Figure 1. Interactions of eIF4E. (a), the organization of the binding sites on eIF4E is 
shown. A cleft in the otherwise globular protein constitutes the cap-binding site. 
Distal from this is a binding site for several proteins. Since these proteins connect to 
the same region on eIF4E, their binding is mutually exclusive. Association of eIF4E 
with the N-terminal domain of eIF4G leads to translationally active complexes, while 
association with the 4E-BPs produces translationally inactive complexes. Association 
with PML or PRH leads to complexes that are less active than free eIF4E for eIF4E-
dependent mRNA export (see text for further explanation). Note that further ligands 
of eIF4E have been described, which appear to compete with eIF4G-binding to this 
protein in a fashion similar to the 4E-BPs. (b), the translationally active eIF4E–eIF4G 
complex in the context of a translated mRNA. The cap-binding activity of eIF4E 
tethers several activities that are associated via the C-terminal domain of eIF4G to the 
mRNA 5’-end: among these are the recruitment to the message of RNA helicase 
activity in the form of eIF4A or eIF4A–eIF4B complexes, the recruitment of the 
ribosome itself via contacts with other 40S-associated eIFs, and circularization of the 
mRNA via contacts with the poly(A) binding protein PAB. 
 
Figure 2. Structural features of the cap-binding complex. (a), chemical structure of an 
mRNA cap (shown for the sequence m7GpppGpGp). Parts of the chemical structure 
corresponding to the cap-analog m7GDP are colored according to the CPK color 
scheme in order to aid comparison with panel b. (b), a detailed view of tryptophan-
stacked m7GDP in cap-bound yeast eIF4E, showing the cap-analog in the CPK color 
scheme and the Trp-residues in yellow. Hydrogen atoms are not shown. (c), lateral 
view of the yeast cap–eIF4E–eIF4G393–490 ternary complex. eIF4E is shown in yellow, 
the eIF4G fragment in blue, and the cap-analog in CPK color scheme. Secondary 
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structure elements visible in the eIF4G-fragment , as well as the short helix of the 
eIF4E N-terminal tail visible in the lower right-hand corner of the image, are induced 
by the interaction of the two proteins since these features cannot be detected in the 
apo-proteins.  
 
Figure 3. The effect of eIF4E on translation, mRNA degradation and mRNA export is 
determined by its protein ligands. Stimulatory effects are represented by green arrows, 
inhibitory effects by red lines. Association of the apo-protein with mRNA caps can 
stimulate the nuclear export of a subset of mRNAs. This function can be repressed by 
binding of PML or PRH. eIF4E must bind to eIF4G in order to be translationally 
active. This association is prevented if eIF4E is bound to a 4E-BP. Based on 
experiments in yeast, eIF4E–4E-BP complexes could potentially inhibit mRNA 
degradation since they efficiently compete with decapping. The relationship between 
eIF4E–eIF4G-cap complex formation and mRNA turnover remains unclear.  
 
 
Figure 4. Models for the transition from translation to mRNA degradation. Based on 
the known properties of the cap-binding complex and of mRNA degradation 
intermediates, two pathways of deadenylation-dependent mRNA degradation can be 
proposed. Both start with a capped, adenylated mRNA that is bound to the cap-
binding complex and efficiently translated. Following co-translational poly(A) 
shortening, the contact between the poly(A) tail and PAB is lost. Whether loss of the 
poly(A) tail leads to the immediate dissociation of PAB from the cap-binding 
complex as depicted, or whether PAB can remain bound to eIF4G in this state, is not 
yet fully understood. In one model (left branch), the loss of contact with the poly(A) 
 30
tail reduces the affinity of the cap-binding complex for the mRNA 5’-end sufficiently 
to lead to accelerated dissociation from the cap-structure, thus making the latter 
accessible to the action of the decapping enzymes DCP1 and DCP2. In an indirect 
model (right branch), the dissociation of PAB from the mRNA 3’-end allows the 
formation of an intermediate complex comprising the decapping enzymes Dcp1 and 
Dcp2, and several additional activities like the enhancers of decapping Edc1 and 2, 
the RNA helicase Dhh1 and the LSm1-7 protein complex (these proteins are here 
collectively denoted as “Decapping factors”). This intermediate complex induces 
dissociation of the cap-binding complex, while at the same time stimulating the 
decapping activity of the Dcps. Upon removal of the cap-structure, the RNA is rapidly 
degraded by 5’-3’ exonucleases. A second pathway of mRNA degradation that 
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